Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov;30(11):6014-6021.
doi: 10.1007/s00330-020-06996-2. Epub 2020 Jun 18.

Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas

Affiliations

Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas

Benjamin Henninger et al. Eur Radiol. 2020 Nov.

Abstract

Objectives: To evaluate magnetic resonance cholangiopancreatography (MRCP) with compressed sensing (CS) for the assessment of branch duct intraductal papillary mucinous neoplasm (BD-IPMN) of the pancreas. For this purpose, conventional navigator-triggered (NT) sampling perfection with application-optimized contrast using different flip angle evolutions (SPACE) MRCP was compared with various CS-SPACE-MRCP sequences in a clinical setting.

Methods: A total of 41 patients (14 male, 27 female, mean age 68 years) underwent 1.5-T MRCP for the evaluation of BD-IPMN. The MRCP protocol consisted of the following sequences: conventional NT-SPACE-MRCP, CS-SPACE-MRCP with long (BHL, 17 s) and short single breath-hold (BHS, 8 s), and NT-CS-SPACE-MRCP. Two board-certified radiologists evaluated image quality, duct sharpness, duct visualization, lesion conspicuity, confidence, and communication with the main pancreatic duct in consensus using a 5-point scale (1-5), with higher scores indicating better quality/delineation/confidence. Maximum intensity projection reconstructions and originally acquired data were used for evaluation. Wilcoxon signed-rank test was used to compare the intra-individual difference between sequences.

Results: BHS-CS-SPACE-MRCP had the highest scores for image quality (3.85 ± 0.79), duct sharpness (3.81 ± 1.05), and duct visualization (3.81 ± 1.01). There was a significant difference compared with NT-CS-SPACE-MRCP (p < 0.05) but no significant difference to the standard NT-SPACE-MRCP (p > 0.05). Concerning diagnostic quality, BHS-CS-SPACE-MRCP had the highest scores in lesion conspicuity (3.95 ± 0.92), confidence (4.12 ± 1.08), and communication (3.8 ± 1.06), significantly higher compared with NT-SPACE-MRCP, BHL-SPACE-MRCP, and NT-CS-SPACE-MRCP (p = <0.05).

Conclusions: MRCP with CS 3D SPACE for the evaluation of BD-IPMN at 1.5 T provides the best results using a short breath-hold sequence. This approach is feasible and an excellent alternative to standard NT 3D MRCP sequences.

Key points: • 1.5-T MRCP with compressed sensing for the evaluation of branch duct IPMN is a feasible method. • Short breath-hold sequences provide the best results for this purpose.

Keywords: Magnetic resonance imaging; Pancreas; Pancreatic intraductal neoplasms.

PubMed Disclaimer

Conflict of interest statement

The authors of this manuscript declare relationships with the following companies: Siemens Healthineers.

Figures

Fig. 1
Fig. 1
Overview of patient inclusion criteria, visualized as a flow chart
Fig. 2
Fig. 2
A 71-year-old female patient with multiple BD-IPMN. a Conventional NT-SPACE-MRCP providing the worst quality with the longest acquisition time (04:13 min). CS-SPACE-MRCP with breath-hold shows the best image quality (image b is BHL and image c is BHS). d NT-CS-SPACE-MRCP with 01:32-min acquisition time also provides only average image quality. Scores were as follows [image quality/duct sharpness/duct visualization/lesion conspicuity/confidence/communication]: (a) NT-SPACE [2/2/2/2/3/2]; (b) BHL-CS-SPACE [4/4/4/4/5/4]; (c) BHS-CS-SPACE [4/5/4/4/5/5]; (d) NT-CS-SPACE [3/3/2/2/2/3] (MIPs are displayed; windowing was adjusted for optimal visualization)
Fig. 3
Fig. 3
A 56-year-old male patient with BD-IPMN. Difference between the sequences for source images (left) and MIPs (right) are shown. a Conventional NT-SPACE-MRCP; the communication between the cystic lesion and the pancreatic duct cannot be visualized (circles). It can only barely be depicted with BHL-CS-SPACE-MRCP (circles, b). c BHS-CS-SPACE-MRCP was able to illustrate the communication in the source images (arrow) which made the diagnosis of a BD-IPMN possible. d NT-CS-SPACE-MRCP showed acceptable image quality, but the communication was also hard to depict due to blurring. Scores were as follows [image quality/duct sharpness/duct visualization/lesion conspicuity/confidence/communication]: (a) NT-SPACE [4/3/3/2/2/1]; (b) BHL-CS-SPACE [3/1/2/2/3/2]; (c) BHS-CS-SPACE [4/4/4/4/4/4]; (d) NT-CS-SPACE [3/3/2/3/3/3]

Similar articles

Cited by

References

    1. O’Neill E, Hammond N, Miller FH. MR imaging of the pancreas. Radiol Clin North Am. 2014;52:757–777. doi: 10.1016/j.rcl.2014.02.006. - DOI - PubMed
    1. Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology. 2017;17:738–753. doi: 10.1016/j.pan.2017.07.007. - DOI - PubMed
    1. Anupindi SA, Victoria T (2008) Magnetic resonance cholangiopancreatography: techniques and applications. Magn Reson Imaging Clin N Am 16:453–466 v - PubMed
    1. Kim SH, Lee JM, Lee ES, et al. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology. 2015;274:723–733. doi: 10.1148/radiol.14132960. - DOI - PubMed
    1. Sodickson A, Mortele KJ, Barish MA, Zou KH, Thibodeau S, Tempany CM. Three-dimensional fast-recovery fast spin-echo MRCP: comparison with two-dimensional single-shot fast spin-echo techniques. Radiology. 2006;238:549–559. doi: 10.1148/radiol.2382032065. - DOI - PubMed